Detalhe da pesquisa
1.
Non-vitamin-K-antagonist oral anticoagulants (NOACs) after acute myocardial infarction: a network meta-analysis.
Cochrane Database Syst Rev
; 1: CD014678, 2024 01 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38264795
2.
Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis.
Cochrane Database Syst Rev
; 12: CD013252, 2019 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31858590
3.
Oral treatment with a zinc complex of acetylsalicylic acid prevents diabetic cardiomyopathy in a rat model of type-2 diabetes: activation of the Akt pathway.
Cardiovasc Diabetol
; 15: 75, 2016 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27153943
4.
Non-Vitamin K Antagonist Oral Anticoagulants in Coronary Artery Disease.
Hamostaseologie
; 42(3): 201-209, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34662918
5.
Anticoagulation in Atherosclerotic Disease.
Hamostaseologie
; 38(4): 240-246, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30332694
6.
Dimethyloxalylglycine treatment of brain-dead donor rats improves both donor and graft left ventricular function after heart transplantation.
J Heart Lung Transplant
; 35(1): 99-107, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26255815
7.
Cochrane corner: NOACs in atrial fibrillation patients post-percutaneous coronary intervention.
Heart
; 106(17): 1293-1295, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32471906